Rao Haris Naseem - 07 Sep 2023 Form 3 Insider Report for NantHealth, Inc.

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Bob Petrou, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
07 Sep 2023
Net transactions value
$0
Form type
3
Filing time
15 Sep 2023, 18:32:11 UTC
Next filing
19 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NHIQ Common Stock 3,846,154 07 Sep 2023 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock acquired by the Reporting Person from the Issuer in a private placement transaction pursuant to that certain Stock Purchase Agreement, dated as of August 28, 2023, by and between the Issuer and certain institutional and accredited investors, each as listed as signatories to the Stock Purchase Agreement.
F2 Shares held by Summus Holdings, a private healthcare investment company, for which the Reporting Person serves as Summus Holdings' Chief Executive Officer, a member of its board of directors and majority shareholder, and has voting and dipositive power over the shares owned by Summus Holdings.

Remarks:

Exhibit 24 - Power of Attorney